nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—ADRB1—obesity	0.204	0.543	CbGaD
Formoterol—ADRB2—obesity	0.172	0.457	CbGaD
Formoterol—ADRB2—Phenylpropanolamine—obesity	0.0913	0.216	CbGbCtD
Formoterol—ADRB1—Phenylpropanolamine—obesity	0.0899	0.213	CbGbCtD
Formoterol—CYP2A6—Bupropion—obesity	0.0649	0.154	CbGbCtD
Formoterol—CYP2C9—Phentermine—obesity	0.0262	0.0622	CbGbCtD
Formoterol—CYP2D6—Phentermine—obesity	0.024	0.0569	CbGbCtD
Formoterol—CYP2C9—Bupropion—obesity	0.0223	0.0529	CbGbCtD
Formoterol—CYP2D6—Bupropion—obesity	0.0204	0.0483	CbGbCtD
Formoterol—CYP2C19—Cimetidine—obesity	0.0197	0.0467	CbGbCtD
Formoterol—CYP2D6—Methamphetamine—obesity	0.0192	0.0455	CbGbCtD
Formoterol—CYP2C9—Cimetidine—obesity	0.0164	0.0388	CbGbCtD
Formoterol—CYP2D6—Cimetidine—obesity	0.015	0.0355	CbGbCtD
Formoterol—CYP2C19—Topiramate—obesity	0.0129	0.0305	CbGbCtD
Formoterol—Isoprenaline—PIK3R1—obesity	0.000726	0.143	CrCbGaD
Formoterol—Fenoterol—ADRB3—obesity	0.000537	0.106	CrCbGaD
Formoterol—Arbutamine—ADRB3—obesity	0.000503	0.0987	CrCbGaD
Formoterol—Labetalol—ADRB3—obesity	0.000357	0.0701	CrCbGaD
Formoterol—Dobutamine—COMT—obesity	0.000328	0.0645	CrCbGaD
Formoterol—Isoprenaline—ADRB3—obesity	0.000262	0.0516	CrCbGaD
Formoterol—Fenoterol—ADRB1—obesity	0.000243	0.0477	CrCbGaD
Formoterol—Arbutamine—ADRB1—obesity	0.000227	0.0446	CrCbGaD
Formoterol—Arformoterol—ADRB1—obesity	0.000221	0.0433	CrCbGaD
Formoterol—Dobutamine—ADRB1—obesity	0.000209	0.0411	CrCbGaD
Formoterol—Fenoterol—ADRB2—obesity	0.000204	0.0401	CrCbGaD
Formoterol—Ritodrine—ADRB2—obesity	0.000204	0.0401	CrCbGaD
Formoterol—Arbutamine—ADRB2—obesity	0.000191	0.0375	CrCbGaD
Formoterol—Arformoterol—ADRB2—obesity	0.000186	0.0365	CrCbGaD
Formoterol—Mediastinal disorder—Orlistat—obesity	0.000183	0.00138	CcSEcCtD
Formoterol—Sleep disorder—Topiramate—obesity	0.000182	0.00137	CcSEcCtD
Formoterol—Dizziness—Diethylpropion—obesity	0.000181	0.00137	CcSEcCtD
Formoterol—Sinusitis—Bupropion—obesity	0.000179	0.00135	CcSEcCtD
Formoterol—Diarrhoea—Cimetidine—obesity	0.000178	0.00135	CcSEcCtD
Formoterol—Gastroenteritis—Topiramate—obesity	0.000178	0.00134	CcSEcCtD
Formoterol—Mental disorder—Orlistat—obesity	0.000178	0.00134	CcSEcCtD
Formoterol—Immune system disorder—Sibutramine—obesity	0.000177	0.00134	CcSEcCtD
Formoterol—Malnutrition—Orlistat—obesity	0.000176	0.00133	CcSEcCtD
Formoterol—Dobutamine—ADRB2—obesity	0.000176	0.0346	CrCbGaD
Formoterol—Arrhythmia—Sibutramine—obesity	0.000175	0.00132	CcSEcCtD
Formoterol—Vomiting—Diethylpropion—obesity	0.000174	0.00131	CcSEcCtD
Formoterol—Nasal congestion—Topiramate—obesity	0.000173	0.0013	CcSEcCtD
Formoterol—Rash—Diethylpropion—obesity	0.000173	0.0013	CcSEcCtD
Formoterol—Dysgeusia—Orlistat—obesity	0.000173	0.0013	CcSEcCtD
Formoterol—Dermatitis—Diethylpropion—obesity	0.000173	0.0013	CcSEcCtD
Formoterol—Dizziness—Cimetidine—obesity	0.000172	0.0013	CcSEcCtD
Formoterol—Headache—Diethylpropion—obesity	0.000172	0.00129	CcSEcCtD
Formoterol—Rhinitis—Bupropion—obesity	0.000171	0.00129	CcSEcCtD
Formoterol—Malnutrition—Sibutramine—obesity	0.000171	0.00129	CcSEcCtD
Formoterol—Back pain—Orlistat—obesity	0.000171	0.00129	CcSEcCtD
Formoterol—Pharyngitis—Bupropion—obesity	0.00017	0.00128	CcSEcCtD
Formoterol—Muscle spasms—Orlistat—obesity	0.00017	0.00128	CcSEcCtD
Formoterol—Urinary tract disorder—Bupropion—obesity	0.000169	0.00127	CcSEcCtD
Formoterol—Oedema peripheral—Bupropion—obesity	0.000168	0.00127	CcSEcCtD
Formoterol—Connective tissue disorder—Bupropion—obesity	0.000168	0.00127	CcSEcCtD
Formoterol—Urethral disorder—Bupropion—obesity	0.000168	0.00126	CcSEcCtD
Formoterol—Tension—Sibutramine—obesity	0.000168	0.00126	CcSEcCtD
Formoterol—Dysgeusia—Sibutramine—obesity	0.000167	0.00126	CcSEcCtD
Formoterol—Nervousness—Sibutramine—obesity	0.000166	0.00125	CcSEcCtD
Formoterol—Vomiting—Cimetidine—obesity	0.000166	0.00125	CcSEcCtD
Formoterol—Back pain—Sibutramine—obesity	0.000165	0.00125	CcSEcCtD
Formoterol—Visual impairment—Bupropion—obesity	0.000165	0.00124	CcSEcCtD
Formoterol—Rash—Cimetidine—obesity	0.000164	0.00124	CcSEcCtD
Formoterol—Dermatitis—Cimetidine—obesity	0.000164	0.00124	CcSEcCtD
Formoterol—Muscle spasms—Sibutramine—obesity	0.000164	0.00124	CcSEcCtD
Formoterol—Ill-defined disorder—Orlistat—obesity	0.000164	0.00123	CcSEcCtD
Formoterol—Headache—Cimetidine—obesity	0.000163	0.00123	CcSEcCtD
Formoterol—Nausea—Diethylpropion—obesity	0.000163	0.00123	CcSEcCtD
Formoterol—Hypoglycaemia—Topiramate—obesity	0.000161	0.00122	CcSEcCtD
Formoterol—Labetalol—ADRB1—obesity	0.000161	0.0317	CrCbGaD
Formoterol—Angioedema—Orlistat—obesity	0.000161	0.00122	CcSEcCtD
Formoterol—Tremor—Sibutramine—obesity	0.00016	0.00121	CcSEcCtD
Formoterol—Malaise—Orlistat—obesity	0.000159	0.0012	CcSEcCtD
Formoterol—Cardiac disorder—Bupropion—obesity	0.000159	0.0012	CcSEcCtD
Formoterol—Ill-defined disorder—Sibutramine—obesity	0.000158	0.00119	CcSEcCtD
Formoterol—Agitation—Sibutramine—obesity	0.000157	0.00118	CcSEcCtD
Formoterol—Angioedema—Sibutramine—obesity	0.000156	0.00118	CcSEcCtD
Formoterol—Palpitations—Orlistat—obesity	0.000156	0.00118	CcSEcCtD
Formoterol—Nausea—Cimetidine—obesity	0.000155	0.00117	CcSEcCtD
Formoterol—Immune system disorder—Bupropion—obesity	0.000154	0.00116	CcSEcCtD
Formoterol—Mediastinal disorder—Bupropion—obesity	0.000154	0.00116	CcSEcCtD
Formoterol—Malaise—Sibutramine—obesity	0.000154	0.00116	CcSEcCtD
Formoterol—Cough—Orlistat—obesity	0.000154	0.00116	CcSEcCtD
Formoterol—Arrhythmia—Bupropion—obesity	0.000153	0.00115	CcSEcCtD
Formoterol—Palpitations—Sibutramine—obesity	0.000151	0.00114	CcSEcCtD
Formoterol—Chest pain—Orlistat—obesity	0.00015	0.00113	CcSEcCtD
Formoterol—Myalgia—Orlistat—obesity	0.00015	0.00113	CcSEcCtD
Formoterol—Mental disorder—Bupropion—obesity	0.00015	0.00113	CcSEcCtD
Formoterol—Anxiety—Orlistat—obesity	0.00015	0.00113	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000149	0.00112	CcSEcCtD
Formoterol—Cough—Sibutramine—obesity	0.000149	0.00112	CcSEcCtD
Formoterol—Malnutrition—Bupropion—obesity	0.000149	0.00112	CcSEcCtD
Formoterol—Discomfort—Orlistat—obesity	0.000148	0.00112	CcSEcCtD
Formoterol—Hypertension—Sibutramine—obesity	0.000147	0.00111	CcSEcCtD
Formoterol—Dry mouth—Orlistat—obesity	0.000147	0.00111	CcSEcCtD
Formoterol—Dehydration—Topiramate—obesity	0.000146	0.0011	CcSEcCtD
Formoterol—Tension—Bupropion—obesity	0.000146	0.0011	CcSEcCtD
Formoterol—Dysgeusia—Bupropion—obesity	0.000146	0.0011	CcSEcCtD
Formoterol—Myalgia—Sibutramine—obesity	0.000145	0.0011	CcSEcCtD
Formoterol—Arthralgia—Sibutramine—obesity	0.000145	0.0011	CcSEcCtD
Formoterol—Chest pain—Sibutramine—obesity	0.000145	0.0011	CcSEcCtD
Formoterol—Anxiety—Sibutramine—obesity	0.000145	0.00109	CcSEcCtD
Formoterol—Nervousness—Bupropion—obesity	0.000145	0.00109	CcSEcCtD
Formoterol—Oedema—Orlistat—obesity	0.000144	0.00109	CcSEcCtD
Formoterol—Anaphylactic shock—Orlistat—obesity	0.000144	0.00109	CcSEcCtD
Formoterol—Back pain—Bupropion—obesity	0.000144	0.00109	CcSEcCtD
Formoterol—Discomfort—Sibutramine—obesity	0.000144	0.00108	CcSEcCtD
Formoterol—Hypokalaemia—Topiramate—obesity	0.000143	0.00108	CcSEcCtD
Formoterol—Muscle spasms—Bupropion—obesity	0.000143	0.00108	CcSEcCtD
Formoterol—Infection—Orlistat—obesity	0.000143	0.00108	CcSEcCtD
Formoterol—Dry mouth—Sibutramine—obesity	0.000142	0.00107	CcSEcCtD
Formoterol—Nervous system disorder—Orlistat—obesity	0.000141	0.00106	CcSEcCtD
Formoterol—Nasopharyngitis—Topiramate—obesity	0.000141	0.00106	CcSEcCtD
Formoterol—Skin disorder—Orlistat—obesity	0.00014	0.00105	CcSEcCtD
Formoterol—Tremor—Bupropion—obesity	0.000139	0.00105	CcSEcCtD
Formoterol—Gastritis—Topiramate—obesity	0.000139	0.00105	CcSEcCtD
Formoterol—Anaphylactic shock—Sibutramine—obesity	0.000139	0.00105	CcSEcCtD
Formoterol—Oedema—Sibutramine—obesity	0.000139	0.00105	CcSEcCtD
Formoterol—Infection—Sibutramine—obesity	0.000138	0.00104	CcSEcCtD
Formoterol—Ill-defined disorder—Bupropion—obesity	0.000138	0.00104	CcSEcCtD
Formoterol—Agitation—Bupropion—obesity	0.000137	0.00103	CcSEcCtD
Formoterol—Asthma—Topiramate—obesity	0.000136	0.00103	CcSEcCtD
Formoterol—Angioedema—Bupropion—obesity	0.000136	0.00103	CcSEcCtD
Formoterol—Tachycardia—Sibutramine—obesity	0.000136	0.00103	CcSEcCtD
Formoterol—Labetalol—ADRB2—obesity	0.000136	0.0266	CrCbGaD
Formoterol—Skin disorder—Sibutramine—obesity	0.000135	0.00102	CcSEcCtD
Formoterol—Malaise—Bupropion—obesity	0.000134	0.00101	CcSEcCtD
Formoterol—Angina pectoris—Topiramate—obesity	0.000133	0.001	CcSEcCtD
Formoterol—Palpitations—Bupropion—obesity	0.000132	0.000992	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Orlistat—obesity	0.000131	0.000989	CcSEcCtD
Formoterol—Bronchitis—Topiramate—obesity	0.000131	0.000987	CcSEcCtD
Formoterol—Insomnia—Orlistat—obesity	0.00013	0.000982	CcSEcCtD
Formoterol—Hypotension—Sibutramine—obesity	0.00013	0.000982	CcSEcCtD
Formoterol—Cough—Bupropion—obesity	0.00013	0.00098	CcSEcCtD
Formoterol—Hypertension—Bupropion—obesity	0.000128	0.000969	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Sibutramine—obesity	0.000127	0.000957	CcSEcCtD
Formoterol—Dyspepsia—Orlistat—obesity	0.000127	0.000956	CcSEcCtD
Formoterol—Arthralgia—Bupropion—obesity	0.000127	0.000956	CcSEcCtD
Formoterol—Chest pain—Bupropion—obesity	0.000127	0.000956	CcSEcCtD
Formoterol—Myalgia—Bupropion—obesity	0.000127	0.000956	CcSEcCtD
Formoterol—Upper respiratory tract infection—Topiramate—obesity	0.000126	0.000954	CcSEcCtD
Formoterol—Anxiety—Bupropion—obesity	0.000126	0.000952	CcSEcCtD
Formoterol—Insomnia—Sibutramine—obesity	0.000126	0.00095	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000126	0.000949	CcSEcCtD
Formoterol—Discomfort—Bupropion—obesity	0.000125	0.000944	CcSEcCtD
Formoterol—Gastrointestinal disorder—Orlistat—obesity	0.000124	0.000937	CcSEcCtD
Formoterol—Dyspnoea—Sibutramine—obesity	0.000124	0.000937	CcSEcCtD
Formoterol—Fatigue—Orlistat—obesity	0.000124	0.000936	CcSEcCtD
Formoterol—Dry mouth—Bupropion—obesity	0.000124	0.000935	CcSEcCtD
Formoterol—Somnolence—Sibutramine—obesity	0.000124	0.000934	CcSEcCtD
Formoterol—Pain—Orlistat—obesity	0.000123	0.000929	CcSEcCtD
Formoterol—Hyperglycaemia—Topiramate—obesity	0.000123	0.000926	CcSEcCtD
Formoterol—Dyspepsia—Sibutramine—obesity	0.000123	0.000925	CcSEcCtD
Formoterol—Anaphylactic shock—Bupropion—obesity	0.000121	0.000916	CcSEcCtD
Formoterol—Oedema—Bupropion—obesity	0.000121	0.000916	CcSEcCtD
Formoterol—Infection—Bupropion—obesity	0.000121	0.00091	CcSEcCtD
Formoterol—Gastrointestinal disorder—Sibutramine—obesity	0.00012	0.000907	CcSEcCtD
Formoterol—Pain—Sibutramine—obesity	0.000119	0.000899	CcSEcCtD
Formoterol—Constipation—Sibutramine—obesity	0.000119	0.000899	CcSEcCtD
Formoterol—Nervous system disorder—Bupropion—obesity	0.000119	0.000898	CcSEcCtD
Formoterol—Isoprenaline—ADRB1—obesity	0.000119	0.0233	CrCbGaD
Formoterol—Feeling abnormal—Orlistat—obesity	0.000119	0.000895	CcSEcCtD
Formoterol—Tachycardia—Bupropion—obesity	0.000119	0.000894	CcSEcCtD
Formoterol—Skin disorder—Bupropion—obesity	0.000118	0.00089	CcSEcCtD
Formoterol—Urinary tract infection—Topiramate—obesity	0.000118	0.00089	CcSEcCtD
Formoterol—Conjunctivitis—Topiramate—obesity	0.000118	0.00089	CcSEcCtD
Formoterol—Gastrointestinal pain—Orlistat—obesity	0.000118	0.000888	CcSEcCtD
Formoterol—Haematuria—Topiramate—obesity	0.000116	0.000873	CcSEcCtD
Formoterol—Feeling abnormal—Sibutramine—obesity	0.000115	0.000866	CcSEcCtD
Formoterol—Urticaria—Orlistat—obesity	0.000114	0.000863	CcSEcCtD
Formoterol—Gastrointestinal pain—Sibutramine—obesity	0.000114	0.000859	CcSEcCtD
Formoterol—Sinusitis—Topiramate—obesity	0.000114	0.000859	CcSEcCtD
Formoterol—Abdominal pain—Orlistat—obesity	0.000114	0.000858	CcSEcCtD
Formoterol—Body temperature increased—Orlistat—obesity	0.000114	0.000858	CcSEcCtD
Formoterol—Hypotension—Bupropion—obesity	0.000114	0.000856	CcSEcCtD
Formoterol—Urticaria—Sibutramine—obesity	0.000111	0.000835	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Bupropion—obesity	0.000111	0.000835	CcSEcCtD
Formoterol—Abdominal pain—Sibutramine—obesity	0.00011	0.000831	CcSEcCtD
Formoterol—Body temperature increased—Sibutramine—obesity	0.00011	0.000831	CcSEcCtD
Formoterol—Insomnia—Bupropion—obesity	0.00011	0.000829	CcSEcCtD
Formoterol—Rhinitis—Topiramate—obesity	0.000109	0.000824	CcSEcCtD
Formoterol—Dyspnoea—Bupropion—obesity	0.000108	0.000817	CcSEcCtD
Formoterol—Pharyngitis—Topiramate—obesity	0.000108	0.000815	CcSEcCtD
Formoterol—Somnolence—Bupropion—obesity	0.000108	0.000814	CcSEcCtD
Formoterol—Urinary tract disorder—Topiramate—obesity	0.000108	0.000811	CcSEcCtD
Formoterol—Oedema peripheral—Topiramate—obesity	0.000107	0.000809	CcSEcCtD
Formoterol—Connective tissue disorder—Topiramate—obesity	0.000107	0.000807	CcSEcCtD
Formoterol—Dyspepsia—Bupropion—obesity	0.000107	0.000806	CcSEcCtD
Formoterol—Urethral disorder—Topiramate—obesity	0.000107	0.000805	CcSEcCtD
Formoterol—Hypersensitivity—Orlistat—obesity	0.000106	0.0008	CcSEcCtD
Formoterol—Visual impairment—Topiramate—obesity	0.000105	0.000792	CcSEcCtD
Formoterol—Gastrointestinal disorder—Bupropion—obesity	0.000105	0.000791	CcSEcCtD
Formoterol—Fatigue—Bupropion—obesity	0.000105	0.00079	CcSEcCtD
Formoterol—Pain—Bupropion—obesity	0.000104	0.000783	CcSEcCtD
Formoterol—Constipation—Bupropion—obesity	0.000104	0.000783	CcSEcCtD
Formoterol—Asthenia—Orlistat—obesity	0.000103	0.000779	CcSEcCtD
Formoterol—Hypersensitivity—Sibutramine—obesity	0.000103	0.000774	CcSEcCtD
Formoterol—Pruritus—Orlistat—obesity	0.000102	0.000768	CcSEcCtD
Formoterol—Cardiac disorder—Topiramate—obesity	0.000101	0.000762	CcSEcCtD
Formoterol—Feeling abnormal—Bupropion—obesity	0.0001	0.000755	CcSEcCtD
Formoterol—Asthenia—Sibutramine—obesity	0.0001	0.000754	CcSEcCtD
Formoterol—Isoprenaline—ADRB2—obesity	9.98e-05	0.0196	CrCbGaD
Formoterol—Gastrointestinal pain—Bupropion—obesity	9.93e-05	0.000749	CcSEcCtD
Formoterol—Pruritus—Sibutramine—obesity	9.86e-05	0.000743	CcSEcCtD
Formoterol—Diarrhoea—Orlistat—obesity	9.85e-05	0.000743	CcSEcCtD
Formoterol—Immune system disorder—Topiramate—obesity	9.84e-05	0.000742	CcSEcCtD
Formoterol—Mediastinal disorder—Topiramate—obesity	9.82e-05	0.00074	CcSEcCtD
Formoterol—Urticaria—Bupropion—obesity	9.65e-05	0.000728	CcSEcCtD
Formoterol—Abdominal pain—Bupropion—obesity	9.6e-05	0.000724	CcSEcCtD
Formoterol—Body temperature increased—Bupropion—obesity	9.6e-05	0.000724	CcSEcCtD
Formoterol—Mental disorder—Topiramate—obesity	9.54e-05	0.00072	CcSEcCtD
Formoterol—Diarrhoea—Sibutramine—obesity	9.53e-05	0.000719	CcSEcCtD
Formoterol—Dizziness—Orlistat—obesity	9.52e-05	0.000718	CcSEcCtD
Formoterol—Malnutrition—Topiramate—obesity	9.48e-05	0.000715	CcSEcCtD
Formoterol—Tension—Topiramate—obesity	9.3e-05	0.000702	CcSEcCtD
Formoterol—Dysgeusia—Topiramate—obesity	9.29e-05	0.0007	CcSEcCtD
Formoterol—Dizziness—Sibutramine—obesity	9.21e-05	0.000695	CcSEcCtD
Formoterol—Nervousness—Topiramate—obesity	9.21e-05	0.000695	CcSEcCtD
Formoterol—Back pain—Topiramate—obesity	9.17e-05	0.000692	CcSEcCtD
Formoterol—Vomiting—Orlistat—obesity	9.15e-05	0.00069	CcSEcCtD
Formoterol—Muscle spasms—Topiramate—obesity	9.12e-05	0.000688	CcSEcCtD
Formoterol—Rash—Orlistat—obesity	9.08e-05	0.000685	CcSEcCtD
Formoterol—Dermatitis—Orlistat—obesity	9.07e-05	0.000684	CcSEcCtD
Formoterol—Headache—Orlistat—obesity	9.02e-05	0.00068	CcSEcCtD
Formoterol—Hypersensitivity—Bupropion—obesity	8.95e-05	0.000675	CcSEcCtD
Formoterol—Tremor—Topiramate—obesity	8.88e-05	0.00067	CcSEcCtD
Formoterol—Vomiting—Sibutramine—obesity	8.86e-05	0.000668	CcSEcCtD
Formoterol—Ill-defined disorder—Topiramate—obesity	8.8e-05	0.000664	CcSEcCtD
Formoterol—Rash—Sibutramine—obesity	8.79e-05	0.000663	CcSEcCtD
Formoterol—Dermatitis—Sibutramine—obesity	8.78e-05	0.000662	CcSEcCtD
Formoterol—Headache—Sibutramine—obesity	8.73e-05	0.000658	CcSEcCtD
Formoterol—Asthenia—Bupropion—obesity	8.72e-05	0.000657	CcSEcCtD
Formoterol—Agitation—Topiramate—obesity	8.71e-05	0.000657	CcSEcCtD
Formoterol—Pruritus—Bupropion—obesity	8.59e-05	0.000648	CcSEcCtD
Formoterol—Nausea—Orlistat—obesity	8.55e-05	0.000645	CcSEcCtD
Formoterol—Malaise—Topiramate—obesity	8.55e-05	0.000645	CcSEcCtD
Formoterol—Palpitations—Topiramate—obesity	8.38e-05	0.000632	CcSEcCtD
Formoterol—Diarrhoea—Bupropion—obesity	8.31e-05	0.000627	CcSEcCtD
Formoterol—Nausea—Sibutramine—obesity	8.28e-05	0.000624	CcSEcCtD
Formoterol—Cough—Topiramate—obesity	8.27e-05	0.000624	CcSEcCtD
Formoterol—Hypertension—Topiramate—obesity	8.19e-05	0.000617	CcSEcCtD
Formoterol—Chest pain—Topiramate—obesity	8.07e-05	0.000609	CcSEcCtD
Formoterol—Arthralgia—Topiramate—obesity	8.07e-05	0.000609	CcSEcCtD
Formoterol—Myalgia—Topiramate—obesity	8.07e-05	0.000609	CcSEcCtD
Formoterol—Anxiety—Topiramate—obesity	8.04e-05	0.000607	CcSEcCtD
Formoterol—Dizziness—Bupropion—obesity	8.03e-05	0.000606	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	8.02e-05	0.000605	CcSEcCtD
Formoterol—Discomfort—Topiramate—obesity	7.98e-05	0.000602	CcSEcCtD
Formoterol—Dry mouth—Topiramate—obesity	7.9e-05	0.000595	CcSEcCtD
Formoterol—Oedema—Topiramate—obesity	7.74e-05	0.000584	CcSEcCtD
Formoterol—Vomiting—Bupropion—obesity	7.72e-05	0.000582	CcSEcCtD
Formoterol—Infection—Topiramate—obesity	7.69e-05	0.00058	CcSEcCtD
Formoterol—Rash—Bupropion—obesity	7.66e-05	0.000578	CcSEcCtD
Formoterol—Dermatitis—Bupropion—obesity	7.65e-05	0.000577	CcSEcCtD
Formoterol—Headache—Bupropion—obesity	7.61e-05	0.000574	CcSEcCtD
Formoterol—Nervous system disorder—Topiramate—obesity	7.59e-05	0.000572	CcSEcCtD
Formoterol—Tachycardia—Topiramate—obesity	7.55e-05	0.00057	CcSEcCtD
Formoterol—Skin disorder—Topiramate—obesity	7.52e-05	0.000567	CcSEcCtD
Formoterol—Hypotension—Topiramate—obesity	7.23e-05	0.000545	CcSEcCtD
Formoterol—Nausea—Bupropion—obesity	7.22e-05	0.000544	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Topiramate—obesity	7.05e-05	0.000532	CcSEcCtD
Formoterol—Insomnia—Topiramate—obesity	7e-05	0.000528	CcSEcCtD
Formoterol—Dyspnoea—Topiramate—obesity	6.9e-05	0.00052	CcSEcCtD
Formoterol—Somnolence—Topiramate—obesity	6.88e-05	0.000519	CcSEcCtD
Formoterol—Dyspepsia—Topiramate—obesity	6.81e-05	0.000514	CcSEcCtD
Formoterol—Gastrointestinal disorder—Topiramate—obesity	6.68e-05	0.000504	CcSEcCtD
Formoterol—Fatigue—Topiramate—obesity	6.67e-05	0.000503	CcSEcCtD
Formoterol—Constipation—Topiramate—obesity	6.62e-05	0.000499	CcSEcCtD
Formoterol—Pain—Topiramate—obesity	6.62e-05	0.000499	CcSEcCtD
Formoterol—Feeling abnormal—Topiramate—obesity	6.38e-05	0.000481	CcSEcCtD
Formoterol—Gastrointestinal pain—Topiramate—obesity	6.33e-05	0.000477	CcSEcCtD
Formoterol—Urticaria—Topiramate—obesity	6.15e-05	0.000464	CcSEcCtD
Formoterol—Abdominal pain—Topiramate—obesity	6.12e-05	0.000461	CcSEcCtD
Formoterol—Body temperature increased—Topiramate—obesity	6.12e-05	0.000461	CcSEcCtD
Formoterol—Hypersensitivity—Topiramate—obesity	5.7e-05	0.00043	CcSEcCtD
Formoterol—Asthenia—Topiramate—obesity	5.55e-05	0.000419	CcSEcCtD
Formoterol—Pruritus—Topiramate—obesity	5.48e-05	0.000413	CcSEcCtD
Formoterol—Diarrhoea—Topiramate—obesity	5.29e-05	0.000399	CcSEcCtD
Formoterol—Dizziness—Topiramate—obesity	5.12e-05	0.000386	CcSEcCtD
Formoterol—Vomiting—Topiramate—obesity	4.92e-05	0.000371	CcSEcCtD
Formoterol—Rash—Topiramate—obesity	4.88e-05	0.000368	CcSEcCtD
Formoterol—Dermatitis—Topiramate—obesity	4.87e-05	0.000368	CcSEcCtD
Formoterol—Headache—Topiramate—obesity	4.85e-05	0.000366	CcSEcCtD
Formoterol—Nausea—Topiramate—obesity	4.6e-05	0.000347	CcSEcCtD
Formoterol—CYP2C9—Metabolism—NAMPT—obesity	5.88e-06	9.12e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOC3—obesity	5.86e-06	9.08e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—obesity	5.85e-06	9.06e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—LIPC—obesity	5.85e-06	9.06e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GCK—obesity	5.85e-06	9.06e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—obesity	5.84e-06	9.05e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOC3—obesity	5.81e-06	9e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—MTHFR—obesity	5.78e-06	8.95e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—obesity	5.77e-06	8.94e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—obesity	5.77e-06	8.94e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SREBF1—obesity	5.75e-06	8.91e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CETP—obesity	5.69e-06	8.82e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PPARA—obesity	5.67e-06	8.79e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PRKCD—obesity	5.66e-06	8.77e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CETP—obesity	5.64e-06	8.74e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SDC1—obesity	5.63e-06	8.72e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GOT2—obesity	5.59e-06	8.67e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SDC1—obesity	5.58e-06	8.64e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR2A—obesity	5.54e-06	8.58e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PRKCD—obesity	5.54e-06	8.58e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AKR1C3—obesity	5.53e-06	8.58e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—C3—obesity	5.53e-06	8.57e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—obesity	5.52e-06	8.55e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—AGT—obesity	5.49e-06	8.51e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AKR1C3—obesity	5.49e-06	8.5e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—FASN—obesity	5.47e-06	8.48e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—BCHE—obesity	5.45e-06	8.45e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SCARB1—obesity	5.45e-06	8.44e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR2A—obesity	5.42e-06	8.4e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—C3—obesity	5.41e-06	8.38e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SCARB1—obesity	5.4e-06	8.37e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOE—obesity	5.38e-06	8.34e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CAV1—obesity	5.33e-06	8.26e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—obesity	5.33e-06	8.26e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOA1—obesity	5.32e-06	8.24e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SREBF1—obesity	5.29e-06	8.2e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IRS2—obesity	5.26e-06	8.15e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP2E1—obesity	5.26e-06	8.15e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—obesity	5.26e-06	8.15e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AGT—obesity	5.25e-06	8.14e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SREBF1—obesity	5.24e-06	8.13e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NQO1—obesity	5.2e-06	8.06e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOE—obesity	5.15e-06	7.98e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—LEP—obesity	5.15e-06	7.98e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IRS2—obesity	5.15e-06	7.98e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GOT2—obesity	5.15e-06	7.97e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AGT—obesity	5.14e-06	7.97e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CAV1—obesity	5.1e-06	7.91e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GOT2—obesity	5.1e-06	7.91e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—obesity	5.09e-06	7.89e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOA1—obesity	5.09e-06	7.89e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—obesity	5.05e-06	7.82e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—LEP—obesity	5.04e-06	7.81e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOE—obesity	5.04e-06	7.81e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—FASN—obesity	5.03e-06	7.8e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—obesity	5.03e-06	7.8e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—BCHE—obesity	5.01e-06	7.77e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—FASN—obesity	4.99e-06	7.74e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CAV1—obesity	4.99e-06	7.73e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SLC2A4—obesity	4.99e-06	7.73e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GCG—obesity	4.99e-06	7.73e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOA1—obesity	4.98e-06	7.72e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—BCHE—obesity	4.97e-06	7.7e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYCS—obesity	4.92e-06	7.63e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ESR1—obesity	4.92e-06	7.62e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PRKCB—obesity	4.86e-06	7.53e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—F2—obesity	4.86e-06	7.53e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3CG—obesity	4.85e-06	7.52e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP2E1—obesity	4.84e-06	7.5e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GGT1—obesity	4.83e-06	7.48e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GOT1—obesity	4.83e-06	7.48e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ESR1—obesity	4.81e-06	7.45e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—BAD—obesity	4.8e-06	7.44e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP2E1—obesity	4.8e-06	7.43e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NQO1—obesity	4.78e-06	7.41e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NCOA1—obesity	4.76e-06	7.37e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—F2—obesity	4.75e-06	7.36e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PRKCB—obesity	4.75e-06	7.36e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NQO1—obesity	4.74e-06	7.35e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—BAD—obesity	4.69e-06	7.27e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—STK11—obesity	4.69e-06	7.27e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP19A1—obesity	4.69e-06	7.27e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PPARG—obesity	4.69e-06	7.26e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3CG—obesity	4.65e-06	7.2e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	4.64e-06	7.2e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—POMC—obesity	4.62e-06	7.16e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	4.6e-06	7.13e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—INS—obesity	4.6e-06	7.12e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IRS1—obesity	4.59e-06	7.12e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GCG—obesity	4.59e-06	7.11e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SLC2A4—obesity	4.59e-06	7.11e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GCG—obesity	4.55e-06	7.05e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SLC2A4—obesity	4.55e-06	7.05e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3CG—obesity	4.55e-06	7.04e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYCS—obesity	4.53e-06	7.01e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IRS1—obesity	4.49e-06	6.96e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYCS—obesity	4.49e-06	6.95e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GGT1—obesity	4.44e-06	6.88e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GOT1—obesity	4.44e-06	6.88e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—POMC—obesity	4.42e-06	6.86e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GGT1—obesity	4.4e-06	6.82e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GOT1—obesity	4.4e-06	6.82e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—INS—obesity	4.4e-06	6.82e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NCOA1—obesity	4.37e-06	6.78e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—COMT—obesity	4.36e-06	6.75e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NCOA1—obesity	4.34e-06	6.72e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCL2—obesity	4.33e-06	6.71e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—POMC—obesity	4.33e-06	6.71e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—STK11—obesity	4.31e-06	6.68e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP19A1—obesity	4.31e-06	6.68e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—INS—obesity	4.3e-06	6.67e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GNB3—obesity	4.3e-06	6.66e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARGC1A—obesity	4.3e-06	6.66e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—HMOX1—obesity	4.28e-06	6.63e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP19A1—obesity	4.27e-06	6.62e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—STK11—obesity	4.27e-06	6.62e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3CD—obesity	4.27e-06	6.61e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IGF1—obesity	4.25e-06	6.59e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AKT2—obesity	4.25e-06	6.59e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCL2—obesity	4.23e-06	6.56e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ALB—obesity	4.21e-06	6.53e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GNAS—obesity	4.18e-06	6.49e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF1—obesity	4.16e-06	6.45e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AKT2—obesity	4.16e-06	6.45e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOB—obesity	4.1e-06	6.35e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3CD—obesity	4.08e-06	6.33e-05	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	4.05e-06	6.27e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SERPINE1—obesity	4.04e-06	6.26e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3R1—obesity	4.03e-06	6.25e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—NOS3—obesity	4.03e-06	6.25e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—COMT—obesity	4.01e-06	6.21e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3CD—obesity	4e-06	6.19e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—COMT—obesity	3.97e-06	6.16e-05	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	3.96e-06	6.13e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GNB3—obesity	3.95e-06	6.13e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARGC1A—obesity	3.95e-06	6.13e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SERPINE1—obesity	3.95e-06	6.13e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HMOX1—obesity	3.93e-06	6.1e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TYK2—obesity	3.93e-06	6.09e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARGC1A—obesity	3.92e-06	6.07e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GNB3—obesity	3.92e-06	6.07e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—LPL—obesity	3.91e-06	6.06e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HMOX1—obesity	3.9e-06	6.05e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—RHOA—obesity	3.9e-06	6.04e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOS3—obesity	3.86e-06	5.98e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3R1—obesity	3.86e-06	5.98e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GNAS—obesity	3.85e-06	5.96e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TYK2—obesity	3.84e-06	5.96e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GPX1—obesity	3.82e-06	5.92e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GNAS—obesity	3.82e-06	5.91e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—RHOA—obesity	3.81e-06	5.91e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3R1—obesity	3.77e-06	5.85e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOS3—obesity	3.77e-06	5.85e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOB—obesity	3.77e-06	5.84e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOB—obesity	3.74e-06	5.79e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3CB—obesity	3.72e-06	5.77e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CD36—obesity	3.72e-06	5.76e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTGS2—obesity	3.69e-06	5.71e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PIK3CA—obesity	3.67e-06	5.69e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—LPL—obesity	3.6e-06	5.58e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PIK3CA—obesity	3.59e-06	5.57e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—LPL—obesity	3.57e-06	5.53e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MTOR—obesity	3.56e-06	5.52e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3CB—obesity	3.56e-06	5.52e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MTHFR—obesity	3.52e-06	5.46e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GPX1—obesity	3.51e-06	5.44e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3CB—obesity	3.48e-06	5.4e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MTOR—obesity	3.48e-06	5.4e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GPX1—obesity	3.48e-06	5.39e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARA—obesity	3.46e-06	5.36e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CD36—obesity	3.42e-06	5.3e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CD36—obesity	3.39e-06	5.25e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—AGT—obesity	3.35e-06	5.19e-05	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—AKT1—obesity	3.31e-06	5.12e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOE—obesity	3.28e-06	5.08e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL6—obesity	3.25e-06	5.04e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CAV1—obesity	3.25e-06	5.04e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOA1—obesity	3.24e-06	5.02e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MTHFR—obesity	3.24e-06	5.02e-05	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—AKT1—obesity	3.23e-06	5.01e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MTHFR—obesity	3.21e-06	4.98e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL6—obesity	3.18e-06	4.93e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARA—obesity	3.18e-06	4.93e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARA—obesity	3.15e-06	4.88e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.1e-06	4.81e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MMP9—obesity	3.09e-06	4.8e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AGT—obesity	3.08e-06	4.77e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AGT—obesity	3.05e-06	4.73e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MMP9—obesity	3.03e-06	4.69e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOE—obesity	3.02e-06	4.68e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MAPK8—obesity	3.01e-06	4.66e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—AKT1—obesity	3e-06	4.65e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOE—obesity	2.99e-06	4.63e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CAV1—obesity	2.99e-06	4.63e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOA1—obesity	2.98e-06	4.62e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CAV1—obesity	2.96e-06	4.59e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3CG—obesity	2.96e-06	4.59e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOA1—obesity	2.96e-06	4.58e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MAPK8—obesity	2.94e-06	4.56e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—AKT1—obesity	2.94e-06	4.55e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARG—obesity	2.86e-06	4.43e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.83e-06	4.39e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—POMC—obesity	2.82e-06	4.37e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—INS—obesity	2.8e-06	4.34e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—STAT3—obesity	2.75e-06	4.26e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3CG—obesity	2.72e-06	4.22e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3CG—obesity	2.7e-06	4.18e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—STAT3—obesity	2.69e-06	4.17e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARG—obesity	2.63e-06	4.07e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARG—obesity	2.6e-06	4.04e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3CD—obesity	2.6e-06	4.03e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—POMC—obesity	2.59e-06	4.02e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—INS—obesity	2.58e-06	3.99e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—POMC—obesity	2.57e-06	3.98e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALB—obesity	2.57e-06	3.98e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MYC—obesity	2.56e-06	3.96e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—INS—obesity	2.55e-06	3.96e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TGFB1—obesity	2.55e-06	3.95e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MYC—obesity	2.5e-06	3.88e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TGFB1—obesity	2.49e-06	3.87e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3R1—obesity	2.46e-06	3.81e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NOS3—obesity	2.46e-06	3.81e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3CD—obesity	2.39e-06	3.71e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3CD—obesity	2.37e-06	3.68e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALB—obesity	2.36e-06	3.66e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALB—obesity	2.34e-06	3.63e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3CB—obesity	2.27e-06	3.51e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3CA—obesity	2.27e-06	3.51e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NOS3—obesity	2.26e-06	3.5e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3R1—obesity	2.26e-06	3.5e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTGS2—obesity	2.25e-06	3.48e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3R1—obesity	2.24e-06	3.47e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NOS3—obesity	2.24e-06	3.47e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3CA—obesity	2.17e-06	3.36e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3CA—obesity	2.12e-06	3.29e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3CB—obesity	2.09e-06	3.23e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3CB—obesity	2.07e-06	3.2e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTGS2—obesity	2.07e-06	3.2e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTGS2—obesity	2.05e-06	3.18e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL6—obesity	1.92e-06	2.98e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL6—obesity	1.88e-06	2.91e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—AKT1—obesity	1.85e-06	2.87e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AKT1—obesity	1.77e-06	2.75e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AKT1—obesity	1.73e-06	2.69e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3CA—obesity	1.38e-06	2.14e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3CA—obesity	1.27e-06	1.97e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3CA—obesity	1.26e-06	1.95e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—AKT1—obesity	1.13e-06	1.75e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AKT1—obesity	1.04e-06	1.61e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AKT1—obesity	1.03e-06	1.6e-05	CbGpPWpGaD
